In 2024, we saw another proactive year for some of the biggest names in medtech as they looked to bolster their ranks through acquisitions. Over the course of the year, the number of billion-dollar sales deals continued to climb, with some companies involved more than once. Analysts even suggested that, in 2025, there could be […]
Carl Zeiss Meditec
Zeiss unveils new robotic vizualization system for neurosurgery
Zeiss Medical Technology announced today that it launched the Kinevo 900 S robotic visualization system for neurosurgery procedures. Jena, Germany-based Zeiss says Kinevo 900 S offers high-quality digital visualization, collaborative assistant functions and connected intelligence. It designed the platform to offer more clarity for complex neurosurgery procedures and for other surgical disciplines. The latest offering […]
Carl Zeiss completes $1B ophthalmic company buy
Carl Zeiss Meditec announced today that it completed its $1 billion acquisition of D.O.R.C. (Dutch Ophthalmic Research Center). In December 2023, Carl Zeiss entered into an agreement to acquire 100% of the shares in D.O.R.C. The Germany-based company acquired DORC from the France-based investment firm Eurazeo, valuing the deal at €985 million (approximately $1.07 billion). […]
Zeiss, Topcon settle trade secret theft lawsuit
Carl Zeiss Meditec said today that it reached a favorable resolution to settle a lawsuit against Topcon subsidiaries regarding trade secrets. The company’s suit against Topcon’s U.S.-based subsidiaries had been pending in the U.S. federal court for the Northern District of California. Zeiss said the settlement reinforces the protection of its trade secrets and “restores […]
FDA approves Zeiss software that treats nearsightedness
Zeiss Medical Technology announced that the FDA approved the VisuMax 800 with Smile Pro software. The Carl Zeiss Meditec unit designed the software to treat nearsightedness, with or without astigmatism. Its latest generation of femtosecond lasers enters the U.S. market with more than 8 million eyes already treated with Smile software. “The increasing global adoption […]
Carl Zeiss Meditec enhances ophthalmic portfolio with $1B acquisition
Carl Zeiss Meditec announced today that it entered into an agreement to acquire 100% of the shares in Dutch Ophthalmic Research Center. The Germany-based company acquired DORC from the France-based investment firm Eurazeo. It expects the acquisition to enhance and complement its broad ophthalmic portfolio and range of digitally connected workflow solutions. The company develops […]
Zeiss to unveil new intraocular lens, other ophthalmic tech
Zeiss Medical Technology intends to unveil new ophthalmic innovations within its cataract and corneal refractive workflows. The Carl Zeiss Meditec unit plans to showcase these technologies at the European Society of Cataract and Refractive Surgery conference next month. As part of its ecosystem, the new offerings bolster Zeiss’ leadership position in ophthalmic diagnostic and surgical […]
FDA clears Zeiss bipolar forceps for electrosurgery
Zeiss Medical Technology announced that it received FDA 510(k) clearance for its MTLawton disposable bipolar forceps. Jena, Germany-based Zeiss designed the forceps with a special copper-base alloy. MTLawton potentially reduces tissue adhesion and subsequent charring during the dissection of tissue. The system also features an extended shaft that helps the forceps reduce visual restrictions in […]
How did medtech companies score on environmental stewardship list?
Medical Design & Outsourcing recently rated the world’s largest medical device companies — the Big 100 — for their sales numbers and R&D spend. Now we can share how some of them scored on an environmental nonprofit’s annual list of companies ranked for their actions on climate change. Not-for-profit organization CDP (Stockholm, Sweden) runs a global disclosure system for […]
Changes at the top for Zeiss ophthalmic biz
Carl Zeiss Meditec announced today that Jim Mazzo will retire from his role as president of ophthalmic devices and head of the ophthalmic devices strategic business unit. Mazzo is slated to continue supporting Zeiss as an advisor, having spent over 40 years in the ophthalmic industry and more than three with Zeiss. His retirement is […]
Zeiss invests in MicroOptx
Carl Zeiss Meditec last week announced that it is a new shareholder of MicroOptx. Minneapolis-based MicroOptx develops minimally invasive glaucoma surgery devices. The technology is designed to provide effective reduction of intraocular pressure with one surgical procedure. Get the full story on our sister site, Medical Design & Outsourcing.
